New Efficacy Data Shows Cimzia(R) (certolizumab pegol) Provides Long-Term Remission of Moderate to Severe Crohn's Disease Regardless of Prior Anti-TNF Exposure, According to Data Presented at DDW

For further Information:

Bert Kelly, Communications and Public Relations Manager, UCB

404.784.6303, [email protected]  

Rich Ferreira, Cooney/Waters Group

212.886.2202, [email protected]